![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SPTSSA mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1618252 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPTSSA mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1350858 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPTSSA mRNA | CTD | PMID:20106945 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPTSSA mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPTSSA mRNA | CTD | PMID:21215274, PMID:33387578 | 3-methylcholanthrene | decreases expression | ISO | RGD:1618252 | 6480464 | Methylcholanthrene results in decreased expression of SPTSSA mRNA | CTD | PMID:25926378 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SPTSSA mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | ISO | RGD:1350858 | 6480464 | Tretinoin results in decreased expression of SPTSSA mRNA | CTD | PMID:33167477 | benzo[a]pyrene | decreases expression | ISO | RGD:1350858 | 6480464 | Benzo(a)pyrene results in decreased expression of SPTSSA mRNA | CTD | PMID:32234424 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SPTSSA mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1350858 | 6480464 | bisphenol A results in decreased expression of SPTSSA mRNA | CTD | PMID:29275510 | buspirone | increases expression | EXP | | 6480464 | Buspirone results in increased expression of SPTSSA mRNA | CTD | PMID:24136188 | butanal | decreases expression | ISO | RGD:1350858 | 6480464 | butyraldehyde results in decreased expression of SPTSSA mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | RGD:1350858 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTSSA mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1350858 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTSSA mRNA | CTD | PMID:35301059 | carbamazepine | affects expression | ISO | RGD:1350858 | 6480464 | Carbamazepine affects the expression of SPTSSA mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | RGD:1618252 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cisplatin | increases expression | ISO | RGD:1350858 | 6480464 | Cisplatin results in increased expression of SPTSSA mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:1350858 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SPTSSA mRNA | CTD | PMID:27392435 | clobetasol | increases expression | ISO | RGD:1618252 | 6480464 | Clobetasol results in increased expression of SPTSSA mRNA | CTD | PMID:27462272 | cobalt dichloride | decreases expression | ISO | RGD:1350858 | 6480464 | cobaltous chloride results in decreased expression of SPTSSA mRNA | CTD | PMID:19376846 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SPTSSA mRNA | CTD | PMID:24386269 | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SPTSSA mRNA | CTD | PMID:30556269 | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SPTSSA mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | ISO | RGD:1350858 | 6480464 | Copper Sulfate results in decreased expression of SPTSSA mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | RGD:1350858 | 6480464 | Cyclosporine results in decreased expression of SPTSSA mRNA | CTD | PMID:20106945, PMID:25562108 | dioxygen | multiple interactions | ISO | RGD:1618252 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPTSSA mRNA | CTD | PMID:30529165 | doxorubicin | decreases expression | ISO | RGD:1350858 | 6480464 | Doxorubicin results in decreased expression of SPTSSA mRNA | CTD | PMID:29803840 | ethanol | affects expression | ISO | RGD:1618252 | 6480464 | Ethanol affects the expression of SPTSSA mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | RGD:1350858 | 6480464 | Ethyl Methanesulfonate results in increased expression of SPTSSA mRNA | CTD | PMID:23649840 | etoposide | affects response to substance | ISO | RGD:1350858 | 6480464 | SPTSSA protein affects the susceptibility to Etoposide | CTD | PMID:16217747 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of SPTSSA mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1618252 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPTSSA mRNA | CTD | PMID:22206623 | formaldehyde | increases expression | ISO | RGD:1350858 | 6480464 | Formaldehyde results in increased expression of SPTSSA mRNA | CTD | PMID:23649840 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of SPTSSA mRNA | CTD | PMID:25539665, PMID:26194646 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SPTSSA mRNA | CTD | PMID:33387578 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of SPTSSA mRNA | CTD | PMID:30467583 | methyl methanesulfonate | increases expression | ISO | RGD:1350858 | 6480464 | Methyl Methanesulfonate results in increased expression of SPTSSA mRNA | CTD | PMID:23649840 | miconazole | decreases expression | ISO | RGD:1618252 | 6480464 | Miconazole results in decreased expression of SPTSSA mRNA | CTD | PMID:27462272 | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of SPTSSA mRNA | CTD | PMID:24136188 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SPTSSA mRNA | CTD | PMID:25729387 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SPTSSA mRNA | CTD | PMID:33387578 | progesterone | increases expression | ISO | RGD:1350858 | 6480464 | Progesterone results in increased expression of SPTSSA mRNA | CTD | PMID:20864642 | resorcinol | increases expression | ISO | RGD:1350858 | 6480464 | resorcinol results in increased expression of SPTSSA mRNA | CTD | PMID:22623647 | silicon dioxide | decreases expression | ISO | RGD:1350858 | 6480464 | Silicon Dioxide analog results in decreased expression of SPTSSA mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | RGD:1350858 | 6480464 | sodium arsenite results in increased expression of SPTSSA mRNA | CTD | PMID:28595984, PMID:34032870 | tert-butyl hydroperoxide | decreases expression | ISO | RGD:1350858 | 6480464 | tert-Butylhydroperoxide results in decreased expression of SPTSSA mRNA | CTD | PMID:15336504 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SPTSSA mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | RGD:1618252 | 6480464 | Carbon Tetrachloride results in decreased expression of SPTSSA mRNA | CTD | PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SPTSSA mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SPTSSA mRNA | CTD | PMID:23411599, PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SPTSSA mRNA | CTD | PMID:25729387 | tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of SPTSSA mRNA | CTD | PMID:31129395 | trichostatin A | affects expression | ISO | RGD:1350858 | 6480464 | trichostatin A affects the expression of SPTSSA mRNA | CTD | PMID:28542535 | trovafloxacin | increases expression | EXP | | 6480464 | trovafloxacin results in increased expression of SPTSSA mRNA | CTD | PMID:24136188 | tungsten | increases expression | ISO | RGD:1618252 | 6480464 | Tungsten results in increased expression of SPTSSA mRNA | CTD | PMID:30912803 | valproic acid | increases expression | ISO | RGD:1350858 | 6480464 | Valproic Acid results in increased expression of SPTSSA mRNA | CTD | PMID:28001369 | |